Manufacturing
Formulation development: which is the direction?
We are in the era of controlled release formulations, but new emerging technologies are coming, such as fixed dose combinations or those with dual release profile
Envi committee final opinion on the SPC manufacturing waiver makes genericists...
The ENVI Committee’s adoption of the Compromise Amendments on the SPC manufacturing waiver proposed regulation make genericists happy and originator disappointed.
Glabal Report
Job market in Life Science sector
A sample of Italian workers have been involved in the research "Talents in the Life Science 2018" of Kelly Services, according to which about two thirds (67%) of the respondents work with contractual forms different from the permanent one
Medical devices in 2030
Shift the focus from cost to value. An analisys of medical device markets and industry direction of next years, till 2030.
R&D
Company
Environment controls: an Industry 4.0 approach
The digital integration of different single control systems operating within a production environment is a key feature of the new paradigm of Industry 4.0 manufacturing. Dos & Donts developed the Hazel® platform to support the needs of the pharmaceutical industry of a better integration and communication of systems, especially to control the strictly regulated cleanroom environment
IRIS guide to the platform for parallel distribution industry users
The new IT platform launched by the European Medicines Agency is based on the Iris Regulatory & Scientific Information Management Platform, to directly and safely manage notifications of medicinal products intended for parallel distribution
Packaging and green economy
The main producers are adapting to new green economy requirements and the packaging of pharmaceutical products are made using recyclable materials such us plastic, paper, glass and aluminum
New rules on safety features
Falsified medicines are often disguised as authentic medicines but may contain ingredients of bad or toxic quality, or in the wrong dosage. As they have not been properly checked for quality, safety and efficacy, as required by strict EU authorisation, they can pose a real risk to your health
Blockchain technology in the pharmaceutical logistics industry
The potential of blockchain technology in the pharmaceutical logistics industry is significant; however, the transition to the effective adoption of these new solutions will require further technological development and the willingness to collaborate on the part of all the actors involved
Looking for philosopher’s stone
Next generation biotech could allow 200 years to live in the coming years. Based on Kris Verburgh, medical doctor interested in preventative medicine and aging and author of The Longevity Code "In the near future, we will see a new biotech age unfolding, in which our health, bodies and lifespan will drastically change"